Aller au contenu
  • Home
  • About us

    About PhinC

    Founded in 2008, PhinC was established with a clear mission: to provide innovative solutions that accelerate and de-risk drug development.

    Our history

    Our values

    Our foundations

    Our vision

  • Expertise

    Quantitative modeling at the heart of every stage of drug development

    Pharmacological modeling enables us to anticipate, rationalize and secure key decisions throughout development.

    Read more ➜
    MIDD Strategy

    Expert advice

    By phase

    Lead Optimization

    Preclinical

    Phase I

    Phase II

    Phase III

    Filing

    Solutions

    PBPK - PBBM Modeling

    Quantitative Systems Pharmacology (QSP)

    PK NCA – CDISC

    PopPK PD Modeling

    QT/QTc Analysis

    Clinical Trial Simulation

    Integrated Phase I Solutions

    Applications

    First in Human (FiH)

    Drug Drug interactions (DDI)

    Special populations

    See case studies ➜

    Compliance

    Quality standards

    Regulatory support

  • Resources

    Resources

    Through expert analyses, field experience, and concrete case studies, our teams illustrate how modeling drives smarter decisions, mitigates risk, and enhances the efficiency of drug development programs.

  • Careers
  • Get in touch
  • Client area

References

Headquarters

36 Rue Victor Basch
Le Classea building
91300 MASSY
FRANCE
Tel: +33 1 76 91 24 60

North America Office

625 Av. du Président-Kennedy
Suite 950
Montreal Quebec H3A 1K2
CANADA
Tel: +1 514 245 4848

Subscribe to newsletter
  • Privacy policy
  • Privacy Policy on Personal Data - Applicants
  • Legal notice
  • Privacy policy
  • Privacy Policy on Personal Data - Applicants
  • Legal notice
Search

Explore PhinC content

Search expertise, case studies, publications, resources and more.

Popular searches: PBPK MIDD QT/QTc case study publications
Français